Ruti Aga's Six-Year Ban: How a Forged Prescription Turned a Two-Year Sanction into Four More Years

Ruti Aga's case begins on 10 September, when the Athletics Integrity Unit (AIU) provisionally suspended her. But the real question isn't 10 September. The real question is why a two-year sanction in this case became four years longer. According to the AIU statement, Aga's sample after winning a half marathon in China in March tested positive for methylprednisolone. Two years for the presence of a prohibited substance, and four years for presenting misleading documents during the investigation — six years total. The arithmetic is clear, but understanding it requires first understanding what methylprednisolone is. Media reports called it a 'prohibited steroid.' That is an incomplete truth. On the WADA Prohibited List, methylprednisolone falls under glucocorticoids (class S9), not anabolic steroids (S1). The difference matters: S9 substances are prohibited only in-competition, and only by injection, oral, or rectal routes. A therapeutic knee injection can be entirely legal out-of-competition — provided no residue remains in the athlete's body at competition time. The hinge of this case is not the drug but the management of timing and route. And that is exactly where Aga's defence sank. The AIU stated that Aga submitted a prescription citing a knee injury for treatment. The problem was that the prescription came from a clinic that did not exist. The prescription was written by a family member with no medical registration. When the clinic was contacted, it stated plainly that the old prescription pad was not theirs. Three independent verification failures — wrong clinic, wrong doctor, wrong source. This is not a filing error. It is a portrait of the medical governance of an athlete running without any credentialed team physician. I have tracked East African road racing cases over the past several years. A pattern is clear: first a substance is found, then the athlete or their inner circle tries to cover it with a white lie, and the sanction doubles. Aga's case belongs to this category. When I placed the two-year presence sanction and the four-year tampering sanction in separate columns in my spreadsheet, one thing emerged: the panel rejected the 'no significant fault' mitigation on the presence charge, otherwise the two years would have been shorter. And the four-year tampering sanction is the WADA Code standard. The athlete destroyed her only line of defence herself. There is a bitter truth here I will not hide. Methylprednisolone has no proven endurance benefit. It reduces swelling and dulls pain. Treating knee inflammation in marathon runners is entirely valid medical practice. So what is the six-year ban for? It is not for the drug but for the attempt to hide it. Had Aga possessed genuine medical records, she could have demonstrated the correct timing of an out-of-competition injection and perhaps no case would have been built at all. The forged prescription extinguished that possibility. But there are two aspects missing from every media report. First, what happens to Aga's 2026 Tokyo Marathon victory? The AIU decision nowhere states that this victory will be annulled. The ban is tied to the March race in China. Unless evidence of an earlier violation emerges, the 2026 win remains her record as an athlete. But for any sponsor, she is now radioactive. Sponsorship in marathon running is thin anyway; the burden of public shame weighs heavier than money. Second aspect is more stinging. In China's label races, large appearance fees, deep East African elite fields, and now increasing AIU scrutiny are colliding in the same place. This collision will set the pattern for future cases. I have written before that an empty domestic calendar is itself news, and the same is happening here — when coverage of Indian athletics on the track shrinks, only such cases make headlines. This is the honest part of my own coverage ledger. If I were to write this case's verdict in one line, it would be this: the four-year addition to the two-year presence sanction came from a forged document, not a fake drug. The lesson for athletes and their managers is clear — in glucocorticoid cases, the path to victory lies not in denial but in correct timing and correct paperwork. And if the six-year count from 10 September is correct, then the next time she contemplates a return to the track, she will be nearly 38. A 2:18 runner in Ethiopian women's marathon may not make the national team, but a 38-year-old with a doping stain — that is not even a question. The real meaning of the sanction is this: it is not six years, it is the end of a career. The question is not whether Aga is guilty. The question is whether the AIU investigation process has enough transparency that an athlete never needs to fabricate a prescription. Until an answer emerges, this case stays 'open' in my column — not in green, but in red.